To test whether EZH2 is associated with transcriptional repression of WNT2, we ectopically expressed WT or F681I, catalytically inactive mutant, EZH2 in CRC cells (HCT116, KM12, and HT15). This evidence concerns the gene EZH2 and colorectal carcinoma.